BGS B&G Foods, Inc.
Food and Kindred Products · NYSE · SEC CIK 1278027 · Fiscal year ends 01/02
Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.7%
TTM net income YoY66.4%
TTM EPS YoY67.1%
Revenue 3-yr CAGR-5.3%
Net income 3-yr CAGR—
Margins
Gross margin21.8%
Operating margin3.7%
Net margin-4.7%
FCF margin5.6%
EBITDA margin7.0%
Returns
ROE-20.4%
ROA-2.9%
ROIC (approx.)2.2%
Asset turnover0.62x
Leverage & solvency
Liabilities / assets87.7%
Debt / equity5.75x
Current ratio2.84x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.48x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue1.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-01-03 | FY20242024-12-28 |
|---|---|---|
| Income statement | ||
| Revenue | $1.83B | $1.93B |
| Cost of revenue | $1.43B | $1.51B |
| Gross profit | $398.82M | $421.95M |
| SG&A expense | $194.95M | $188.07M |
| Operating income | $97.15M | -$177.28M |
| Pretax income | -$47.73M | -$330.51M |
| Income tax | -$4.48M | -$79.26M |
| Net income | -$43.26M | -$251.25M |
| EBITDA | $163.37M | -$108.66M |
| EPS (basic) | -0.54 | -3.18 |
| EPS (diluted) | -0.54 | -3.18 |
| Dividends declared per share | 0.76 | 0.76 |
| Weighted avg. shares (diluted) | 79.75M | 79.01M |
| Balance sheet | ||
| Cash & equivalents | $56.29M | $50.58M |
| Receivables | $140.70M | $172.26M |
| Inventory | $420.77M | $511.23M |
| Current assets | $739.82M | $781.44M |
| PP&E, net | $253.43M | $278.12M |
| Goodwill | $543.81M | $548.23M |
| Intangibles | $1.19B | $1.29B |
| Total assets | $2.83B | $2.99B |
| Current liabilities | $222.84M | $236.87M |
| Short-term debt | $4.50M | $5.62M |
| Long-term debt | $1.95B | $2.01B |
| Total debt | $1.95B | $2.02B |
| Total liabilities | $2.38B | $2.47B |
| Shareholders' equity | $452.93M | $524.81M |
| Net debt | $1.89B | $1.97B |
| Shares outstanding | 79.98M | 79.14M |
| Cash flow statement | ||
| Operating cash flow | $101.40M | $130.91M |
| Capital expenditure | $30.65M | $27.26M |
| Free cash flow | $70.75M | $103.65M |
| Investing cash flow | $39.32M | -$27.68M |
| Financing cash flow | -$135.81M | -$92.96M |
| Depreciation & amortization | $66.22M | $68.61M |
| Stock-based compensation | $13.32M | $8.66M |
| Dividends paid | $60.60M | $60.04M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.